Synthaverse SA
F:6NQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Synthaverse SA
F:6NQ
|
PL |
|
Digital Magics SpA
MIL:DM
|
IT |
|
Pulsar Group PLC
F:8TB
|
UK |
|
Boustead Projects Ltd
SGX:AVM
|
SG |
|
NanoTech Gaming Inc
OTC:NTGL
|
US |
|
U
|
UC&GN International Corp
TPEX:3603
|
TW |
|
G
|
Graystone Company Inc
OTC:GYST
|
US |
|
W
|
WITS Corp
TPEX:4953
|
TW |
|
China Green Agriculture Inc
NYSE:CGA
|
CN |
|
L
|
Longyan Zhuoyue New Energy Co Ltd
SSE:688196
|
CN |
|
X
|
Xcana Petroleum Corp
OTC:XCPT
|
US |
|
Martifer SGPS SA
F:FRW
|
PT |
|
Antioquia Gold Inc (Pre-Reincorporation)
XTSX:AGD
|
CA |
|
SLJ Global Tbk PT
IDX:SULI
|
ID |
|
P
|
PNGS Gargi Fashion Jewellery Ltd
BSE:543709
|
IN |
|
Kukje Pharma Co Ltd
KRX:002720
|
KR |
|
E
|
Eurasia Mining PLC
XBER:EUH
|
UK |
|
Basilea Pharmaceutica AG
SIX:BSLN
|
CH |
|
Nicolas Miguet et Associes SA
PAR:MLNMA
|
FR |
Bankruptcy Probability
Synthaverse SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Synthaverse SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PL |
S
|
Synthaverse SA
WSE:SVE
|
230.3m PLN |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
451.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Synthaverse SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Synthaverse SA has total debt of 2m PLN. This includes both short-term (0 PLN) and long-term (2m PLN) debt.
You can find a full breakdown on its Balance Sheet.
